Overview

Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate and compare the efficacy and safety of escalating doses of BF2.649 and BF2.649 add on Modafinil on cataplexy in patients with narcolepsy
Phase:
Phase 3
Details
Lead Sponsor:
Bioprojet
Treatments:
Armodafinil
Modafinil